PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell
PD-1/PD-L1 interaction blocked by antibodies, freeing T cell to kill tumor cell www.fn-test.com 2018-10-22 KEYTRUDA (anti-PD-1(Programmed cell death protein 1) antibody) get approval of FDA. KEYTRUDA, Also called Pembrolizumab, is an anti-PD-1(Programmed cell death protein 1) antibody from humanized( from Mouse), which has been approved by the FDA. KEYTRUDA Could inhibit the PD-1/PD-L1 …